HS6ST2 was found to be significantly linked with the infiltrating levels of naive B cells across cancers in the TCGA data, particularly in breast invasive carcinoma, brain lower grade glioma, and ovarian serous cystadenocarcinoma (Supplementary Table S1). Here, HS6ST2 is linked to cancer.